Global Olanzapine API Market Research Report 2023

Publication ID:

PB504230977

Publication Date:

April 14, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

Olanzapine is an atypical antipsychotic drugs, it is suitable for schizophrenia and other severe positive symptoms (for example: delusions, hallucinations, thought disorder, hostility and suspicion) and / or negative symptoms (such as: apathy acute and maintenance treatment, emotional and social withdrawal, poverty of speech) psychosis. In this report, we research and analyze the olanzapine, which used for manufacturing the olanzapine tablets.
The global Olanzapine API market was valued at US$ 193 million in 2022 and is anticipated to reach US$ 225.5 million by 2029, witnessing a CAGR of 2.2% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Olanzapine key players include Lilly, Teva Pharmaceutical, Dr. Reddy's Laboratories, Apotex Inc, Hansoh Pharmaceutical, etc. Global top five manufacturers hold a share over 85%.
North America is the largest market, with a share over 70%, followed by Asia, which has a share over 25%.
In terms of product, Patent is the largest segment, with a share about 55%. And in terms of application, the largest application is Olanzapine Tablets, followed by Daily Commodities, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Olanzapine API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Olanzapine API.
The Olanzapine API market size, estimations, and forecasts are provided in terms of output/shipments (Ton) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Olanzapine API market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Olanzapine API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Dr. Reddy's Laboratories
Inke
Solara Active Pharma
Teva API
Cadila Pharmaceuticals
Anant Labs
Lavybens Pharma
Jubilant Generics
Venkatasai Life Sciences
Hangzhou Longshine Bio-tech
Neuland Lab
Segment by Type
Oral Grade
Injection Grade
Segment by Application
Olanzapine Tablets
Olanzapine Injection
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Olanzapine API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Olanzapine API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Olanzapine API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Olanzapine API Market Overview
1.1 Product Definition
1.2 Olanzapine API Segment by Type
1.2.1 Global Olanzapine API Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Oral Grade
1.2.3 Injection Grade
1.3 Olanzapine API Segment by Application
1.3.1 Global Olanzapine API Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Olanzapine Tablets
1.3.3 Olanzapine Injection
1.4 Global Market Growth Prospects
1.4.1 Global Olanzapine API Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Olanzapine API Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Olanzapine API Production Estimates and Forecasts (2018-2029)
1.4.4 Global Olanzapine API Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Olanzapine API Production Market Share by Manufacturers (2018-2023)
2.2 Global Olanzapine API Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Olanzapine API, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Olanzapine API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Olanzapine API Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Olanzapine API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Olanzapine API, Product Offered and Application
2.8 Global Key Manufacturers of Olanzapine API, Date of Enter into This Industry
2.9 Olanzapine API Market Competitive Situation and Trends
2.9.1 Olanzapine API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Olanzapine API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Olanzapine API Production by Region
3.1 Global Olanzapine API Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Olanzapine API Production Value by Region (2018-2029)
3.2.1 Global Olanzapine API Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Olanzapine API by Region (2024-2029)
3.3 Global Olanzapine API Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Olanzapine API Production by Region (2018-2029)
3.4.1 Global Olanzapine API Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Olanzapine API by Region (2024-2029)
3.5 Global Olanzapine API Market Price Analysis by Region (2018-2023)
3.6 Global Olanzapine API Production and Value, Year-over-Year Growth
3.6.1 North America Olanzapine API Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Olanzapine API Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Olanzapine API Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Olanzapine API Production Value Estimates and Forecasts (2018-2029)
4 Olanzapine API Consumption by Region
4.1 Global Olanzapine API Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Olanzapine API Consumption by Region (2018-2029)
4.2.1 Global Olanzapine API Consumption by Region (2018-2023)
4.2.2 Global Olanzapine API Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Olanzapine API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Olanzapine API Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Olanzapine API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Olanzapine API Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Olanzapine API Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Olanzapine API Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Olanzapine API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Olanzapine API Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Olanzapine API Production by Type (2018-2029)
5.1.1 Global Olanzapine API Production by Type (2018-2023)
5.1.2 Global Olanzapine API Production by Type (2024-2029)
5.1.3 Global Olanzapine API Production Market Share by Type (2018-2029)
5.2 Global Olanzapine API Production Value by Type (2018-2029)
5.2.1 Global Olanzapine API Production Value by Type (2018-2023)
5.2.2 Global Olanzapine API Production Value by Type (2024-2029)
5.2.3 Global Olanzapine API Production Value Market Share by Type (2018-2029)
5.3 Global Olanzapine API Price by Type (2018-2029)
6 Segment by Application
6.1 Global Olanzapine API Production by Application (2018-2029)
6.1.1 Global Olanzapine API Production by Application (2018-2023)
6.1.2 Global Olanzapine API Production by Application (2024-2029)
6.1.3 Global Olanzapine API Production Market Share by Application (2018-2029)
6.2 Global Olanzapine API Production Value by Application (2018-2029)
6.2.1 Global Olanzapine API Production Value by Application (2018-2023)
6.2.2 Global Olanzapine API Production Value by Application (2024-2029)
6.2.3 Global Olanzapine API Production Value Market Share by Application (2018-2029)
6.3 Global Olanzapine API Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Dr. Reddy's Laboratories
7.1.1 Dr. Reddy's Laboratories Olanzapine API Corporation Information
7.1.2 Dr. Reddy's Laboratories Olanzapine API Product Portfolio
7.1.3 Dr. Reddy's Laboratories Olanzapine API Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Dr. Reddy's Laboratories Main Business and Markets Served
7.1.5 Dr. Reddy's Laboratories Recent Developments/Updates
7.2 Inke
7.2.1 Inke Olanzapine API Corporation Information
7.2.2 Inke Olanzapine API Product Portfolio
7.2.3 Inke Olanzapine API Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Inke Main Business and Markets Served
7.2.5 Inke Recent Developments/Updates
7.3 Solara Active Pharma
7.3.1 Solara Active Pharma Olanzapine API Corporation Information
7.3.2 Solara Active Pharma Olanzapine API Product Portfolio
7.3.3 Solara Active Pharma Olanzapine API Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Solara Active Pharma Main Business and Markets Served
7.3.5 Solara Active Pharma Recent Developments/Updates
7.4 Teva API
7.4.1 Teva API Olanzapine API Corporation Information
7.4.2 Teva API Olanzapine API Product Portfolio
7.4.3 Teva API Olanzapine API Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Teva API Main Business and Markets Served
7.4.5 Teva API Recent Developments/Updates
7.5 Cadila Pharmaceuticals
7.5.1 Cadila Pharmaceuticals Olanzapine API Corporation Information
7.5.2 Cadila Pharmaceuticals Olanzapine API Product Portfolio
7.5.3 Cadila Pharmaceuticals Olanzapine API Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Cadila Pharmaceuticals Main Business and Markets Served
7.5.5 Cadila Pharmaceuticals Recent Developments/Updates
7.6 Anant Labs
7.6.1 Anant Labs Olanzapine API Corporation Information
7.6.2 Anant Labs Olanzapine API Product Portfolio
7.6.3 Anant Labs Olanzapine API Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Anant Labs Main Business and Markets Served
7.6.5 Anant Labs Recent Developments/Updates
7.7 Lavybens Pharma
7.7.1 Lavybens Pharma Olanzapine API Corporation Information
7.7.2 Lavybens Pharma Olanzapine API Product Portfolio
7.7.3 Lavybens Pharma Olanzapine API Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Lavybens Pharma Main Business and Markets Served
7.7.5 Lavybens Pharma Recent Developments/Updates
7.8 Jubilant Generics
7.8.1 Jubilant Generics Olanzapine API Corporation Information
7.8.2 Jubilant Generics Olanzapine API Product Portfolio
7.8.3 Jubilant Generics Olanzapine API Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Jubilant Generics Main Business and Markets Served
7.7.5 Jubilant Generics Recent Developments/Updates
7.9 Venkatasai Life Sciences
7.9.1 Venkatasai Life Sciences Olanzapine API Corporation Information
7.9.2 Venkatasai Life Sciences Olanzapine API Product Portfolio
7.9.3 Venkatasai Life Sciences Olanzapine API Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Venkatasai Life Sciences Main Business and Markets Served
7.9.5 Venkatasai Life Sciences Recent Developments/Updates
7.10 Hangzhou Longshine Bio-tech
7.10.1 Hangzhou Longshine Bio-tech Olanzapine API Corporation Information
7.10.2 Hangzhou Longshine Bio-tech Olanzapine API Product Portfolio
7.10.3 Hangzhou Longshine Bio-tech Olanzapine API Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Hangzhou Longshine Bio-tech Main Business and Markets Served
7.10.5 Hangzhou Longshine Bio-tech Recent Developments/Updates
7.11 Neuland Lab
7.11.1 Neuland Lab Olanzapine API Corporation Information
7.11.2 Neuland Lab Olanzapine API Product Portfolio
7.11.3 Neuland Lab Olanzapine API Production, Value, Price and Gross Margin (2018-2023)
7.11.4 Neuland Lab Main Business and Markets Served
7.11.5 Neuland Lab Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Olanzapine API Industry Chain Analysis
8.2 Olanzapine API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Olanzapine API Production Mode & Process
8.4 Olanzapine API Sales and Marketing
8.4.1 Olanzapine API Sales Channels
8.4.2 Olanzapine API Distributors
8.5 Olanzapine API Customers
9 Olanzapine API Market Dynamics
9.1 Olanzapine API Industry Trends
9.2 Olanzapine API Market Drivers
9.3 Olanzapine API Market Challenges
9.4 Olanzapine API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Dr. Reddy's Laboratories
Inke
Solara Active Pharma
Teva API
Cadila Pharmaceuticals
Anant Labs
Lavybens Pharma
Jubilant Generics
Venkatasai Life Sciences
Hangzhou Longshine Bio-tech
Neuland Lab

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂